Before your start treatment, let your doctor know:
You use contact lenses. You cannot use contact lenses while on treatment with BLENREP
You have recently started, or are currently, taking any other medications, or if you have any allergies
You are a driver, as BLENREP may cause problems with your eyes that may affect your ability to drive or use machines
You are pregnant, breastfeeding, or thinking about having a child, as you will be advised to go for fertility counselling and advised to use effective contraception for 4 months
If you have, or might have had, hepatitis B in the past, as BLENREP may cause a reactivation of the virus. Symptoms include worsening tiredness, yellowing of your skin or the white parts of your eyes, and/or dark urine
During your treatment, let your doctor know:
BLENREP has been known to cause some more severe side effects. Let your doctor know if:
You develop any breathing-related symptoms that worry you
You experience any bruising or bleeding that is unusual
You experience any symptoms up to 24 hours after your BLENREP infusion such as flushing, chills, fever, difficulty breathing, rapid heartbeat, or a drop in blood pressure
If you have, or may have had, hepatitis B in the past and experience symptoms such as worsening tiredness, yellowing of the skin or the white parts of the eyes, and/or dark urine.
Remember
Use preservative-free artificial tears. These can be provided by your care team or bought over the counter. You should use these 4x a day during treatment with BLENREP.
Please refer to the Patient Information Leaflet for more information about taking BLENREP, including blood tests before and during BLENREP treatment.
If you experience any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at: https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or uksafety@gsk.com.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See information in paragraph above to see how to report side effects.
BLENREP is a registered trademark of the GlaxoSmithKline group of companies
